Braf protein mutation and its significancy within patients with melanoma
Introduction and purpose: This review aims to analyze BRAF mutation significancy and its influence on progression and therapy methods within patients with melanoma. Material and method: This review was mainly based on articles collected in Pubmed in years 2004-2018. The research was done by look...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Book |
| Published: |
Kazimierz Wielki University,
2022-08-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_cdb606c1d8ef4d26b45b4c8b9a231444 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Julia Kuchnicka |e author |
| 700 | 1 | 0 | |a Aleksandra Kuchnicka |e author |
| 700 | 1 | 0 | |a Katarzyna Kosz |e author |
| 700 | 1 | 0 | |a Klaudia Remjasz |e author |
| 700 | 1 | 0 | |a Natalia Zarankiewicz |e author |
| 700 | 1 | 0 | |a Martyna Zielińska |e author |
| 700 | 1 | 0 | |a Klaudia Sapuła |e author |
| 700 | 1 | 0 | |a Jakub Aleksandrowicz |e author |
| 700 | 1 | 0 | |a Wojciech Siedlecki |e author |
| 245 | 0 | 0 | |a Braf protein mutation and its significancy within patients with melanoma |
| 260 | |b Kazimierz Wielki University, |c 2022-08-01T00:00:00Z. | ||
| 500 | |a 10.12775/JEHS.2022.12.08.076 | ||
| 500 | |a 2391-8306 | ||
| 520 | |a Introduction and purpose: This review aims to analyze BRAF mutation significancy and its influence on progression and therapy methods within patients with melanoma. Material and method: This review was mainly based on articles collected in Pubmed in years 2004-2018. The research was done by looking through keywords as follows "braf kinase", "braf mutation", "melanoma" "wemurafenib". Results: The selected studies have demonstrated that it is justified to identify patient with BRAF mutation due to it's influence on treatment's method choosing. Conclusions: Citied researches have proven BRAF mutation significancy in growth and progressions of many malignant tumors. Further tests are likely to not only prolong life expectancy within patients with melanoma, but also being a source of crucial knowledge about tumors development. | ||
| 546 | |a EN | ||
| 546 | |a ES | ||
| 546 | |a PL | ||
| 546 | |a RU | ||
| 546 | |a UK | ||
| 690 | |a braf kinase | ||
| 690 | |a braf mutation | ||
| 690 | |a melanoma | ||
| 690 | |a wemurafenib | ||
| 690 | |a Education | ||
| 690 | |a L | ||
| 690 | |a Sports | ||
| 690 | |a GV557-1198.995 | ||
| 690 | |a Medicine | ||
| 690 | |a R | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Journal of Education, Health and Sport, Vol 12, Iss 8 (2022) | |
| 787 | 0 | |n https://apcz.umk.pl/JEHS/article/view/39472 | |
| 787 | 0 | |n https://doaj.org/toc/2391-8306 | |
| 856 | 4 | 1 | |u https://doaj.org/article/cdb606c1d8ef4d26b45b4c8b9a231444 |z Connect to this object online. |